Additional information
| Weight | 0.94 oz |
|---|
SAVE 20% Original price was: $72.00.$57.60Current price is: $57.60.
-20%578 in stock
Dual-peptide blend combining a GHRH analog (Mod GRF 1-29) with the ghrelin receptor agonist Ipamorelin. These act through complementary pathways — GHRH receptor and ghrelin receptor — producing synergistic pulsatile GH release in research models. The no-DAC form preserves natural GH pulsatility with a shorter duration of action. Research areas include combined-pathway GH secretion, body composition, and age-related somatopause investigation. For research use only — not for human consumption.
A new batch of CJC-1295 (NO DAC) + Ipamorelin 5mg+5mg is on the way. Samples will be sent to Janoshik upon receipt, and updated COAs will be posted here as results come in.
Due to recent supply chain and international shipping disruptions, some Batch 002 inventory may include vials produced at different points within our supplier’s production cycle. As a result, researchers may notice minor packaging variations, including differences in vial caps.
These products were sourced from the same established manufacturers we have worked with for ongoing quality and third-party testing. That said, we want to be transparent that Batch 002 may not represent a single uninterrupted production run.
We are already working with our suppliers to strengthen batch-control, packaging, and documentation protocols before Batch 003.
| Weight | 0.94 oz |
|---|
Due to recent supply chain and international shipping disruptions, some Batch 002 inventory may include vials produced at different points within our supplier’s production cycle. As a result, researchers may notice minor packaging variations, including differences in vial caps.
These products were sourced from the same established manufacturers we have worked with for ongoing quality and third-party testing. That said, we want to be transparent that Batch 002 may not represent a single uninterrupted production run.
We are already working with our suppliers to strengthen batch-control, packaging, and documentation protocols before Batch 003.